ORION: A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world Setting (clinicaltrials.gov) - Oct 28, 2026 - P=N/A | N=3000 | Recruiting | Sponsor: Sanofi
New trial • Real-world evidence • CNS Disorders • Multiple Sclerosis
|